Clinical Trials Logo
  1. Home
  2. Interstitial Lung Diseases
  3. NCT01211015
  4. Details
NCT01211015 Clinical Trial

Endoplasmic Reticulum Stress in Chronic Respiratory Diseases

Interstitial Lung Diseases Clinical Trial

Official title:
Endoplasmic Reticulum (ER) Stress in Patients With Various Chronic Pulmonary Diseases

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT01211015
Other study ID # RCPD ER stress
Secondary ID
Status Recruiting
Phase N/A
First received September 28, 2010
Last updated September 28, 2010
Start date July 2010

Study information
Verified date September 2010
Source Chonbuk National University
Contact Yong Chul Lee, MD, phD
Phone 82-63-250-1664
Email leeyc@chonbuk.ac.kr
Is FDA regulated No
Health authority Korea: Institutional Review Board
Study type Observational

Clinical Trial Summary

Aim: To investigate whether ER stress is implicated in the pathogenesis of various pulmonary disorders

Measurement:

1. Unfolded protein responses (UPRs) in blood (PBMCs)of patients

1. CHOP

2. GRP 78 and so on

2. Unfolded protein responses (UPRs) in blood (PBMCs)of healthy controls

1. CHOP

2. GRP 78 and so on

Recruitment information / eligibility
Status Recruiting
Enrollment 50
Est. completion date
Est. primary completion date
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

- > 18 yrs

- Definitive diagnosis as chronic pulmonary diseases by physician

Exclusion Criteria:

- Any other chronic medical illness such as DM, HTN, and other malignancy

Study Design

Observational Model: Case Control, Time Perspective: Prospective

Related Conditions & MeSH terms

Locations
Country Name City State
Korea, Republic of Chonbuk National University Hospital Jeonju Jeonbuk

Sponsors (1)
Lead Sponsor Collaborator
Chonbuk National University

Country where clinical trial is conducted

Korea, Republic of, 

See also
  Status Clinical Trial Phase
Recruiting NCT05828953 - Anlotinib Capsules in the Treatment for IPF/PF-ILDs Phase 2/Phase 3
Active, not recruiting NCT02951416 - Clinical Course of Interstitial Lung Diseases: European IPF Registry and Biobank
Recruiting NCT00470327 - A Study of the Natural Progression of Interstitial Lung Disease (ILD)
Completed NCT00512967 - The Occurence of Inflammation and Oxidative Stress in Lung Diseases N/A
Completed NCT02689102 - Confocal Laser Endomicroscopy and Optical Coherence Tomography for Diagnosing ILD. N/A
Completed NCT02796781 - Autologous Lung Stem Cell Transplantation in Patients With Interstitial Lung Diseases Phase 1/Phase 2
Completed NCT00129701 - Can we Reduce Hospital Attendance Without Compromising Care by the Use of Telephone Consultation N/A
Recruiting NCT04855305 - Optimizing and Standardizing 129Xe Gas Exchange MRI to Visualize Regional Therapy Response in Interstitial Lung Disease Phase 2
Recruiting NCT01858259 - Treatment and Prevention of Progression of Interstitial Lung Disease in Systemic Sclerosis N/A
Recruiting NCT06068647 - Ultrasound and Respiratory Physiological Signals in Lung Diseases N/A
Enrolling by invitation NCT05455437 - Monitoring and Evaluation Study of Project ECHO for ILD
Recruiting NCT04370158 - Interstitial Lung Diseases Cohort Study in China
Enrolling by invitation NCT05727852 - Breath Analysis and Arterial Stiffness in Patients With Respiratory Diseases
Completed NCT02711657 - Fibrocytes in Rheumatoid Arthritis, Asthma and Interstitial Lung-disease. N/A
Active, not recruiting NCT00267800 - Database of Interstitial Lung Diseases N/A
Completed NCT02763540 - Pathological Comparisons of Surgical Open Lung Biopsies and Cryobiopsies in Non-IPF ILD N/A
Recruiting NCT06036719 - Interstitial Lung Disease: A Study From Infancy to Elderly Including Relatives
Completed NCT02549248 - Nanoparticles Analysis in Lung and Bronchi During Various Pulmonary Interstitial Diseases and Relationships With Their Aetiology N/A
Enrolling by invitation NCT02509364 - Study of the Etiology and Immunological Pathogenesis in Acute Exacerbation of Idiopathic Pulmonary Fibrosis (AE-IPF) N/A
Completed NCT00741572 - Individual Sensitivity for Interstitial Lung Diseases N/A